PHILADELPHIA, October 21, 2015 — Clinical research must produce consistent, reproducible results to be of real value. But too often, underlying decisions are based on opinions and not on well-defined, objective criteria, complicating things and making objectivity impossible.
Nicky Dodsworth, Vice President for Global Quality Assurance at Premier Research, will address this issue at the Research Quality Association’s 2015 Annual Conference in Leeds, U.K. Her presentation, Working towards a SMARTER Tomorrow, is set for Wednesday, Nov. 11, at 11 a.m.
Drawing on more than 25 years of experience in quality assurance, Dodsworth will examine areas where contract research organizations can be more effective and efficient in generating high-quality study data, starting by reaching agreement on some basics — for example, defining what constitutes quality.
Later in November, Dodsworth will speak on Key GCP Updates at the Institute of Clinical Research’s Ethics and GCP Forum, Nov. 20 in London. She will present a summary of changes in regulations and guidelines related to good clinical practices.
About Premier Research
Premier Research is a leading contract research organization serving the needs of biotechnology, pharmaceutical, and medical device companies worldwide. The company has a wealth of experience in the execution of global, regional, and local clinical development programs, with a special focus on addressing unmet needs in such areas as analgesia, CNS, rare diseases, medical device and diagnostics, and pediatric research. Premier Research operates in 50 countries and employs more than 1,000 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. With its mission to improve productivity in clinical development, the company aligns itself with the mission of its customers to bring new medical treatments to patients promptly, accurately, and cost-effectively.